Category Archives: Hepatic Cell

Hepatic Cell News is an online publication and email newsletter covering the top research on hepatocytes and liver diseases.
Subscribe
The publications featured in Hepatic Cell News are expertly selected by our in-house editorial team from high impact, peer-reviewed academic journals. The newsletter covers areas including the culturing and characterization of hepatocytes, liver stem cells, and the pathogenesis of conditions such as liver cirrhosis and hepatocellular carcinoma. Additionally, we provide the latest updates on broader news, upcoming events, and job postings to keep the global liver research community connected!

Mechano-Modulatory Synthetic Niches for Liver Organoid Derivation

Scientists demonstrated the establishment of biopsy-derived human liver organoids without the use of animal components at any step of the process. Their approach opens up exciting perspectives for the establishment of protocols for liver organoid-based regenerative medicine.
[Nature Communications]
Sorrentino, G., Rezakhani, S., Yildiz, E., Nuciforo, S., Heim, M. H., Lutolf, M. P., & Schoonjans, K. (2020). Mechano-modulatory synthetic niches for liver organoid derivation. Nature Communications, 11(1), 3416. https://doi.org/10.1038/s41467-020-17161-0 Cite
Full Article

Continue reading “Mechano-Modulatory Synthetic Niches for Liver Organoid Derivation”

Bookmark

No account yet? Register

0
Share

Suppressing DRP1-Mediated Mitochondrial Fission and Mitophagy Increases Mitochondrial Apoptosis of Hepatocellular Carcinoma Cells in the Setting of Hypoxia

Hepatocellular carcinoma (HCC) cells were subjected to hypoxia and then mitophagy was quantified. The role of dynamin-related protein 1 (DRP1) in hypoxia-induced HCC mitophagy was determined
[Oncogenesis]
Lin, X.-H., Qiu, B.-Q., Ma, M., Zhang, R., Hsu, S.-J., Liu, H.-H., … Chen, R.-X. (2020). Suppressing DRP1-mediated mitochondrial fission and mitophagy increases mitochondrial apoptosis of hepatocellular carcinoma cells in the setting of hypoxia. Oncogenesis, 9(7), 1–13. https://doi.org/10.1038/s41389-020-00251-5 Cite
Full Article

Continue reading “Suppressing DRP1-Mediated Mitochondrial Fission and Mitophagy Increases Mitochondrial Apoptosis of Hepatocellular Carcinoma Cells in the Setting of Hypoxia”

Bookmark

No account yet? Register

0
Share

How Scientific Societies Are Weathering the Pandemic’s Financial Storm

As meetings worldwide have been called off, postponed or moved online because of the pandemic, organizations are trying to weather the cost of cancelling meetings while grappling with the long-term effects that the pandemic could have on their activities and on the research community.
[Nature]
Editorial

Continue reading “How Scientific Societies Are Weathering the Pandemic’s Financial Storm”

Bookmark

No account yet? Register

0
Share

‘I Feel Like I Am Not Welcome’: Medical, Doctoral Students from Abroad Grapple with Uncertainty from New ICE Rules

International students completing their medical and doctoral degrees in the US are wrestling with frustration and uncertainty following the release of federal rules this week that could bar them from staying in the country.
[STAT]
Press Release

Continue reading “‘I Feel Like I Am Not Welcome’: Medical, Doctoral Students from Abroad Grapple with Uncertainty from New ICE Rules”

Bookmark

No account yet? Register

0
Share

Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H2158 for the Treatment of Chronic Hepatitis B Virus Infection

Assembly Biosciences, Inc. have announced that the US FDA has granted Fast Track designation to ABI-H2158 (2158) for the treatment of patients with chronic hepatitis B infection. 2158 is Assembly’s second-generation core inhibitor, which is being evaluated in an ongoing global Phase II trial.
[Assembly Biosciences, Inc.]
Press Release

Continue reading “Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H2158 for the Treatment of Chronic Hepatitis B Virus Infection”

Bookmark

No account yet? Register

0
Share

Enanta Pharmaceuticals Announces Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B Virus

Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, has announced advancements in its hepatitis B virus program evaluating EDP-514 across different patient populations.
[Enanta Pharmaceuticals, Inc.]
Press Release

Continue reading “Enanta Pharmaceuticals Announces Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B Virus”

Bookmark

No account yet? Register

0
Share

Mechano-Modulatory Synthetic Niches for Liver Organoid Derivation

Scientists demonstrated the establishment of biopsy-derived human liver organoids without the use of animal components at any step of the process. Their approach opens up exciting perspectives for the establishment of protocols for liver organoid-based regenerative medicine.
[Nature Communications]
Sorrentino, G., Rezakhani, S., Yildiz, E., Nuciforo, S., Heim, M. H., Lutolf, M. P., & Schoonjans, K. (2020). Mechano-modulatory synthetic niches for liver organoid derivation. Nature Communications, 11(1), 3416. https://doi.org/10.1038/s41467-020-17161-0 Cite
Full Article

Continue reading “Mechano-Modulatory Synthetic Niches for Liver Organoid Derivation”

Bookmark

No account yet? Register

0
Share

‘Disturbing and Cruel.’ Universities Blast New Visa Rule for International Students

A new US immigration policy, which threatens to revoke visas for certain international students if they are not taking in-person classes, is stirring panic and confusion and causing some universities to push back with lawsuits.
[Science]
Editorial

Continue reading “‘Disturbing and Cruel.’ Universities Blast New Visa Rule for International Students”

Bookmark

No account yet? Register

0
Share

The Emerging Role of Ferroptosis in Non-Cancer Liver Diseases: Hype or Increasing Hope?

Researchers summarize the central molecular machinery of ferroptosis, describe the role of ferroptosis in non-cancer hepatic disease conditions and discuss the potential to manipulate ferroptosis as a therapeutic strategy.
[Cell Death & Disease]
The emerging role of ferroptosis in non-cancer liver diseases: hype or increasing hope? | Cell Death & Disease. (n.d.). Retrieved July 9, 2020, from https://www.nature.com/articles/s41419-020-2732-5 Cite
Full Article

Continue reading “The Emerging Role of Ferroptosis in Non-Cancer Liver Diseases: Hype or Increasing Hope?”

Bookmark

No account yet? Register

0
Share

Celastrol Inhibits Ezrin-Mediated Migration of Hepatocellular Carcinoma Cells

Scientists showed that ROCK2 is a novel target of celastrol and inhibition of ROCK2 suppressed elicited ezrin activation and liver cancer cell migration.
[Scientific Reports]
Du, S., Song, X., Li, Y., Cao, Y., Chu, F., Durojaye, O. A., … Ding, X. (2020). Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells. Scientific Reports, 10(1), 11273. https://doi.org/10.1038/s41598-020-68238-1 Cite
Full Article

Continue reading “Celastrol Inhibits Ezrin-Mediated Migration of Hepatocellular Carcinoma Cells”

Bookmark

No account yet? Register

0
Share

US Bars International Students from Online-Only Learning in Fall

Since higher education institutions ended in-person classes in March due to the COVID-19 pandemic, there has been uncertainty over what classes will look like in the fall. Universities will soon have to come up with an answer.
[The Scientist]
Editorial

Continue reading “US Bars International Students from Online-Only Learning in Fall”

Bookmark

No account yet? Register

0
Share

SLC46A1 Contributes to Hepatic Iron Metabolism by Importing Heme in Hepatocytes

The recombinant adeno-associated virus vectors were used to hepatic-specifically inhibit SLC46A1 expression to observe its effects on hepatic iron metabolism. The abilities of SLC46A1 in importing heme and folate, and consequent alterations of iron content in hepatocytes were determined and effects of iron on SLC46A1 expression were investigated both in vitro and in vivo.
[Metabolism-Clinical and Experimental]
Li, H., Wang, D., Wu, H., Shen, H., Lv, D., Zhang, Y., … Li, M. (2020). SLC46A1 contributes to hepatic iron metabolism by importing heme in hepatocytes. Metabolism, 154306. https://doi.org/10.1016/j.metabol.2020.154306 Cite
Abstract

Continue reading “SLC46A1 Contributes to Hepatic Iron Metabolism by Importing Heme in Hepatocytes”

Bookmark

No account yet? Register

0
Share
Share